Side-by-side comparison of AI visibility scores, market position, and capabilities
Amsterdam ethical chocolate company at €200M revenue 2025 (+33% growth) with US +86% growth; fair-trade direct-sourcing mission competing with Lindt and Alter Eco for premium ethical chocolate market share.
Tony's Chocolonely is an Amsterdam, Netherlands-based ethical chocolate company — privately held, with its mission branded into the product itself — producing premium chocolate bars with a proprietary unequal chunk design (representing the unequal distribution of wealth in the cocoa supply chain) across the Netherlands, Belgium, UK, Germany, and US markets, generating €200 million in revenue in fiscal year 2025 (+33% year-over-year growth) with US market sales growing +86% year-over-year and 8.2% Netherlands market share in the chocolate category. Founded in 2005 by Dutch journalist Teun van de Graaf (the "Tony" in the company name) after investigating child labor and modern slavery in West African cocoa farming, Tony's built a brand around the mission to make 100% slave-free chocolate the norm in the industry.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.